EULAR systemic sclerosis recommendations now include immunosuppressantsJune 5, 2023Lupus & Connective Tissue Diseases
Encouraging telitacicept results reported in phase 3 for lupus, phase 2 for Sjögren’sJune 2, 2023Lupus & Connective Tissue Diseases
Enthesitis, arthritis, tenosynovitis linked to dupilumab use for atopic dermatitisJune 1, 2023Psoriatic ArthritisSpondyloarthropathies
Two biologics show no difference in axial spondyloarthritis radiographic progression over 2 yearsJune 1, 2023SpondyloarthropathiesAnkylosing spondylitis
Lupus nephritis: Hopes, questions arise for baricitinibJune 1, 2023Lupus & Connective Tissue Diseases
ILD risk elevated in RA, PsA after starting biologic or targeted synthetic DMARDsJune 1, 2023Psoriatic ArthritisRheumatoid Arthritis
Multiple successive biologic to biosimilar switches deemed safe and effectiveMay 31, 2023Mixed Topics
First prospective study finds pregnancies with Sjögren’s to be largely safeMay 26, 2023Lupus & Connective Tissue Diseases
